[THREE CASES OF DRUG-INDUCED PNEUMONIA CAUSED BY MESALAZINE]

Norimichi Akiyama1, Koshi Yokomura, Tsuyoshi Nozue

  • 1Department of Respiratory Medicine, Seirei Mikatahara Hospital.

Arerugi = [Allergy]
|January 5, 2016
PubMed

Insights

Mesalazine can cause drug-induced pneumonia in ulcerative colitis patients. Early detection through monitoring cough or fever is crucial for good prognosis with treatment cessation or corticosteroids.

Area of Science:

  • Pulmonology
  • Gastroenterology
  • Pharmacology

Context:

  • Ulcerative colitis is a chronic inflammatory bowel disease.
  • Mesalazine is a common oral treatment for ulcerative colitis.
  • Drug-induced lung injury is an important consideration in patients on medication.

Purpose:

  • To report three cases of mesalazine-induced pneumonia.
  • To review the clinical presentation and prognosis of mesalazine-induced pneumonia.
  • To raise awareness among clinicians regarding this adverse effect.

Summary:

  • Three cases of drug-induced pneumonia secondary to mesalazine treatment for ulcerative colitis are presented.
  • Mesalazine-induced pneumonia often mimics eosinophilic pneumonia or organizing pneumonia.
  • Prognosis is generally good with drug cessation or corticosteroid therapy.

Impact:

  • Highlights the potential for mesalazine to cause pulmonary toxicity.
  • Emphasizes the importance of monitoring for respiratory symptoms in patients treated with mesalazine.
  • Suggests that early recognition and intervention can lead to favorable outcomes for drug-induced pneumonia.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.3K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
37
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.1K
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
611
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.0K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.0K